The global cuffless blood pressure monitor market size is expected to reach USD 1,312.5 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to advance at a CAGR of 10.9% from 2023 to 2030. The increasing prevalence of hypertension is expected to drive the growth of the market for cuffless blood pressure monitors. They are a type of wearable device that can measure blood pressure without the need for a large inflatable cuff.
These devices are becoming increasingly popular among individuals with hypertension, as they offer a more convenient, economical, and non-invasive way to monitor blood pressure. According to the World Health Organization, over 1.28 million people aged 30-79 worldwide suffer from hypertension, with the majority residing in low and middle-income countries. The COVID-19 pandemic has led to a significant increase in the utilization of home blood pressure monitoring devices. As a result, the market experienced substantial growth during the pandemic period.
However, the demand for these devices is expected to remain strong even in the post-pandemic period, thus contributing to the market growth. A key factor for the high demand for home blood pressure monitoring devices is the prevalence of chronic diseases such as hypertension. Additionally, the rising geriatric population and the growing risk of lifestyle-associated disorders, such as obesity, among a wide population have further driven the demand for these devices. There is a high demand for cuffless blood pressure monitoring devices particularly, due to their convenience and ease of use.
The market is anticipated to expand due to the increasing rate of government approval for products, and new launches by key market players. For instance, in July 2022, LiveMetric receiv[ed FDA approval for its cuffless blood pressure sensor. The device is designed as a smartwatch and can monitor blood pressure changes 24/7 by tracking the wrist's radial artery without calibration; the device has also received the CE mark in Europe.
Request a free sample copy or view report summary: Cuffless Blood Pressure Monitor Market Report
The wrist-based segment dominated the market in 2022. The increasing adoption of smartwatches and fitness trackers has been one of the driving factors behind the growth of wrist-based BP monitors
The hospital segment is expected to account for a substantial share in the market for cuffless blood pressure monitors, due to the increasing prevalence of hypertension, the convenience and accuracy of cuffless BP monitors, and the growing trend towards remote patient monitoring, which are factors contributing to the adoption of these devices in hospitals
North America has established a strong regional position in the market in 2022, owing to the increasing prevalence of hypertension and cardiovascular diseases in the regional population
Asia Pacific is estimated to expand at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging regional economies such as China and India
Grand View Research has segmented the global cuffless blood pressure monitor marketbased on type, end-use, and region:
Cuffless Blood Pressure Monitor Type Outlook (Revenue, USD Million, 2018 - 2030)
Wrist-based
Finger-based Monitors
Armband-based Monitors
Cuffless Blood Pressure Monitor End-use Outlook (Revenue, USD Million, 2018 - 2030)
Home Healthcare Settings
Hospitals
Diagnostics Center
Other Healthcare Facilities
Cuffless Blood Pressure Monitor Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Companies in the Cuffless Blood Pressure Monitor Market
Omron
CardiacSense
Valencell, Inc.
SOMNOmedics GmbH
Blumio
Biospectal
Aktiia
Equate Health
Fourth Frontier Technologies LLC
A&D Medical
Biobeat Technologies
CHARMCARE
Healthstats International Pte. Ltd.
LiveMetric
Huawei Device Co., Ltd.
"The quality of research they have done for us has been excellent..."